CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 120 enrolled
Drug / intervention
Galantamine +1 moredrug
Likely dose
Galantamine 8 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00809835
NCT00809835Phase 2Completed

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals

Yale University·interventional·Posted Dec 17, 2008·Updated Jan 30, 2019

In Brief

A Phase 2 clinical trial evaluating Galantamine and Computer Assisted Cognitive Behavioral Therapy (CBT) for Cocaine Dependence. Completed, enrolled 120 participants across 2 sites.

Detailed Summary

We are testing to see if Galantamine, a learning enhancing medication, will help methadone maintained cocaine abusers with their learning and memory specific to CBT using an innovative CBT computer program.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 17, 2008
Enrollment StartDec 1, 2007
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7.1 yearsPosted 17.5 years ago

Interventions

Galantaminedrug

Daily 8 mg galantamine capsule

Computer Assisted Cognitive Behavioral Therapy (CBT)behavioral

CBT a psychotherapeutic approach that addresses dysfunctional emotions, maladaptive behaviors and cognitive processes and contents through a number of goal-oriented, explicit systematic procedures. The name refers to behavior therapy, cognitive therapy, and to therapy based upon a combination of basic behavioral and cognitive principles and research.